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Abstract
Introduction: To develop and test a diabetes risk score to predict incident diabetes in an elderly Spanish Mediterranean
population at high cardiovascular risk.
Materials and Methods: A diabetes risk score was derived from a subset of 1381 nondiabetic individuals from three centres
of the PREDIMED study (derivation sample). Multivariate Cox regression model ß-coefficients were used to weigh each risk
factor. PREDIMED-personal Score included body-mass-index, smoking status, family history of type 2 diabetes, alcohol
consumption and hypertension as categorical variables; PREDIMED-clinical Score included also high blood glucose. We
tested the predictive capability of these scores in the DE-PLAN-CAT cohort (validation sample). The discrimination of Finnish
Diabetes Risk Score (FINDRISC), German Diabetes Risk Score (GDRS) and our scores was assessed with the area under curve
(AUC).
Results: The PREDIMED-clinical Score varied from 0 to 14 points. In the subset of the PREDIMED study, 155 individuals
developed diabetes during the 4.75-years follow-up. The PREDIMED-clinical score at a cutoff of $6 had sensitivity of 72.2%,
and specificity of 72.5%, whereas AUC was 0.78. The AUC of the PREDIMED-clinical Score was 0.66 in the validation sample
(sensitivity = 85.4%; specificity = 26.6%), and was significantly higher than the FINDRISC and the GDRS in both the derivation
and validation samples.
Discussion: We identified classical risk factors for diabetes and developed the PREDIMED-clinical Score to determine those
individuals at high risk of developing diabetes in elderly individuals at high cardiovascular risk. The predictive capability of
the PREDIMED-clinical Score was significantly higher than the FINDRISC and GDRS, and also used fewer items in the
questionnaire.
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Introduction
Type 2 diabetes mellitus (T2DM) is one of the most common
chronic diseases worldwide, affecting more than 285 million
people in 2010. Its prevalence has increased overwhelmingly in
recent years in parallel to the obesity epidemics [1,2]. Recently, it
has been estimated that the number of adults with diabetes will
increase between 2010 and 2030 by 69% and 20% in developing
and industrialized countries, respectively [2]. The increase in the
prevalence of T2DM across the world has become an important
public health problem given that it ranks among the leading causes
of blindness, renal failure lower limb amputation, and is also a
significant risk factor for coronary heart disease and stroke, thus
increasing mortality [3] and increasing human and financial public
health costs [4].
Strong evidence from several studies has demonstrated that
T2DM could be prevented by diet and other lifestyle modifications
in high-risk individuals (reviewed by [5]) [6,7]. Thus, it is
important the earlier detection of individuals at high risk for
diabetes to lead to this target population the intensive preventive
interventions [8,9].
Simple prediction tools that can identify those individuals at
high risk of developing T2DM could reduce the cost and
inconvenience of screening [10]. Several multivariate risk scores
PLoS ONE | www.plosone.org 1 March 2012 | Volume 7 | Issue 3 | e33437
based on anthropometric measurements, lifestyle factors and
simple laboratory markers have been developed to identify healthy
individuals at high risk [8,9,11,12], but the great majority of these
scores have been designed and validated using either North
American or European study populations [13]. Furthermore, most
studies have been done in healthy young or middle-aged
individuals from the general population. Because various diabetes
risk factors (e.g. hypertension, abdominal obesity, beta-cell
function decline…) could change with age and age has been
considered an important non modifiable risk factor of incident
diabetes [8,11]. It is important to derive a risk score for elderly
population, who is usually attended by Primary Care clinicians.
To our knowledge, no risk score for predicting incident diabetes
have been developed in elderly Spanish individuals. Therefore, the
main aim of the present study was to develop a diabetes risk score
for elderly Spanish population at high cardiovascular risk using
information routinely collected or simple laboratory measures,
which could effectively predict incident diabetes and be applied in
daily clinical practice. The score was developed in a cohort of non-
diabetic individuals from the PREDIMED study and tested in an
independent Spanish cohort (DE-PLAN-CAT project). We also
assessed and compared the predictive capability of PREDIMED
diabetes risk scores to other diabetes risk scores developed in
European populations in both cohorts.
Materials and Methods
For PREDIMED Study the respective local institutional review
boards (Hospital Universitari Sant Joan de Reus and Fundacio´
Gol i Gurina) approved the study protocol and all participants
provided written informed consent. For DE-PLAN-CAT Project
the research ethics board of the Jordi Gol Research Institute
(Barcelona, Spain) approved the protocol, and all participants gave
written informed consent.
The PREDIMED study (PREvencio´n con DIeta MEDiterra´-
nea) is a large, parallel-group, multicenter, randomized, controlled
clinical trial which aims to assess the effects of the Mediterranean
diet on the primary prevention of cardiovascular disease (CVD)
(www.predimed.org and www.predimed.es). The PREDIMED
study is being conducted in Spain. Recruitment took place
between October 2003 and January 2009, and the 7447
participants were randomly assigned to one of three interventions
(two Mediterranean diets enriched with extra virgin olive oil or
mixed nuts and a control low-fat diet designed by the American
Heart Association). The design and methods used in the
PREDIMED study have been described elsewhere [14].
The present report describes a nested study aimed at
longitudinally assess the predictive value of classical markers of
incident diabetes and develop a diabetes risk score for elderly
Spanish individuals. The 1381 candidates included in the
derivation sample were all non diabetic Caucasian individuals
recruited in PREDIMED centres in Navarra (n = 650), Reus
(n = 418) and Barcelona (n = 313). They were men aged 55-80
years and women aged 60-80 years, who were free of CVD at
baseline but fulfilled at least three or more coronary heart disease
risk factors: current smoking, hypertension (blood pressure .140/
90 mmHg or treatment with antihypertensive medication),
hypertriglyceridemia (serum triglycerides $150 mg/dL or requir-
ing treatment), low plasma HDL-cholesterol (#40 mg/dL in men
and #50 mg/dL in women), overweight or obesity (BMI$25 kg/
m2), and family history of premature CVD (#55 years in men and
#60 years in women). The exclusion criteria for the PREDIMED
study were any severe chronic illness, previous history of CVD,
alcohol or drug abuse, BMI$40 kg/m2 and history of allergy or
intolerance to olive oil or nuts. The participants in the derivation
sample were free of diabetes at baseline because one purpose was
to assess new onset T2DM during follow-up. The median follow-
up was 6.0 years (mean 4.75 years, minimum 3 months -
maximum 8.2 years). At baseline examination and yearly in
follow-up visits, trained personnel performed anthropometric and
blood pressure measurements and obtained samples of fasting
blood. Weight and height were measured with light clothing and
no shoes with calibrated scales and a wall-mounted stadiometer,
respectively; waist circumference was measured midway between
the lowest rib and the iliac crest using an anthropometric tape;
blood pressure was measured using a validated oscillometer
[Omron HEM705CP, Hoofddorp, Netherlands] in triplicate with
a 5-min interval between each measurement, and the mean of
these values was recorded. We also administered a 137-item
validated food frequency questionnaire [15]; the validated Spanish
version of the Minnesota Leisure Time Physical Activity
Questionnaire [16]; and a 47-item questionnaire about education,
lifestyle, history of illnesses and medication use. Samples of serum,
EDTA plasma, and urine were coded, shipped to central
laboratories, and stored at 280uC until analysis. Centralized
laboratory analyses were performed on frozen serum samples
obtained in fasting conditions. Serum glucose, cholesterol, and
triglyceride levels were measured using standard enzymatic
automated methods. HDL-cholesterol was measured by enzymatic
procedure after precipitation.
The validation sample was an active public health program
(DE-PLAN) carried out in Catalonia (Spain) [17]. The design of
DE-PLAN-CAT/PREDICE has been described elsewhere
[18,19]. This cohort was used to externally validate the predictive
capability of the scores previously developed in the derivation
sample. The derivation sample included all the 552 participants in
the DE-PLAN-CAT project. They were also Spanish Caucasian
individuals without diabetes, but younger (45–75 years) than the
individuals in the PREDIMED population. They were screened
using the Finnish diabetes risk score – FINDRISC questionnaire
and a 2-h oral glucose tolerance test, and the subjects were
characterized according to their future risk of T2DM [8]. All
subjects who had a high risk of T2DM (FINDRISC score .14
and/or prediabetes diagnosis criteria at blood test) were
randomized to two lifestyle interventions and included in the
present analysis. All subjects with prevalent diabetes, severe
psychiatric disease, chronic kidney or liver disease or blood
disorders were excluded. The DE-PLAN-CAT intervention
consisted of two steps (initial and further reinforcement) and two
elective interventions (informative or intensive). The usual care
intervention consisted of giving information to the participants
about diet and cardiovascular health but without an individual
program; on the other hand, the intensive DE-PLAN-CAT
educational program consisted of a six-hour educational program
recommending the same Mediterranean diet used in the
PREDIMED study. Participants were followed for a median
period of 4.2 years of follow-up that was almost the same as in the
PREDIMED study (mean 3.8 years, minimum 4 months -
maximum 5.3 years) [18,19].
The information gathered was comparable to the PREDIMED
study; all participants underwent a physical examination and
medical history, and gave information about their smoking status,
diet, alcohol consumption habits and physical activity. Lipid
profile and glucose determinations were also performed at
baseline.
Methods and parameters used for the diagnosis of incident
diabetes were the same in both studies. New onset diabetes was
diagnosed using American Diabetes Association criteria [20],
Risk Score to Predict Type 2 Diabetes Mellitus
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namely fasting plasma glucose (FPG) $126 mg/dL ($7 mmol/L)
or 2-h plasma glucose $200 mg/dL ($11.1 mmol/L) after a 75 g
oral glucose load, measured yearly. A second test using the same
criteria was required for confirmation. Cases were ascertained by a
clinical Event Committee in the PREDIMED study.
We developed a series of multivariate Cox regression models to
produce risk functions for detecting incident diabetes in the
PREDIMED Study. We developed two different predictive
models: one of them contained easily obtained clinical variables,
such as anthropometric parameters (sex, age, BMI, waist
circumference), lifestyle factors (smoking status, alcohol consump-
tion, physical activity) and categorical nutritional variables
(consumption of vegetables, fruit, red meat, fish, coffee and other
foods); the other contained the same variables but also components
of the Metabolic Syndrome, defined by the updated criteria of the
National Cholesterol Education Program Adult Treatment Panel
III (NCEP, 2001). Abdominal obesity was defined as a waist
circumference of $102 cm in men or $88 cm in women. Low
HDL-cholesterol was defined as ,40 mg/dL (,0.9 mmol/L) in
men or ,50 mg/dL (,1.2 mmol/L) in women. The MS
(Metabolic Syndrome) was considered to have a component of
hypertriglyceridemia when triglyceride concentrations were
$150 mg/dL ($1.7 mmol/L) or when subjects were receiving
fibrate treatment. Hypertension was defined as a blood pressure
level of $130/85 mmHg or when subjects were receiving
antihypertensive medication. Hyperglycemia was defined as a
FPG concentration of $100 mg/dL ($5.4 mmol/L). Finally, to
develop the diabetes risk score we selected only those variables that
were statistically significant (P,0.05). The risk factors considered
in the first model (the PREDIMED-personal model) were:
categories of BMI ($27 or ,27 kg/m2), smoking status (current
smoker or non-smoker), alcohol consumption ($3 standard drink
units for men or $1.5 for women or less than these amounts), a
family history of T2DM (only when it was present in a first degree
relative, including mother, father or siblings) and the presence or
absence of hypertension at baseline. The second model (the
PREDIMED-clinical model) included the same variables as in the
first model but also a categorical variable of FPG concentrations.
Coefficients (b) of the models were used to assign a weight value
for each variable. The PREDIMED-personal and the PRE-
DIMED-clinical diabetes risk scores were calculated as the sum of
these weights. The sensitivity (that is to say, the probability that the
test will be positive for subjects who will develop diabetes in the
future) and, specificity (the probability that the test will be negative
for subjects without diabetes) with 95% CIs were calculated for the
scores. Then, receiver-operating characteristic (ROC) curves were
plotted for the scores; the sensitivity was plotted on the y-axis, and
the false positive rate (1-specificity) was plotted on the x-axis. If the
AUC is 1.0, there is a cut point for the variable at which there is
perfect discrimination into cases and no cases of incident diabetes.
The scores derived in the PREDIMED study subset were tested in
the DE-PLAN-CAT project as an external validation sample to
assess their diagnostic properties on an independent sample; for
this purpose we used areas under the curve (AUC). We first
estimated each subject’s probability of developing diabetes on the
basis of the derived risk functions produced in the PREDIMED
study. We also compared the performance of our scores with other
scores by assigning all our subjects a FINDRISC score and a
GDRS. The questions that we used to determine the GDRS were
the same as in the original score.
The German Diabetes risk score included anthropometric
parameters and lifestyle factors such as categories of age, waist
circumference and height; being or not physically active, have
been diagnosed of high blood pressure, the intake of dietetics fiber,
the consumption of meat, the intake of alcohol and coffee, and the
smoking habit [11]. The FINDRISC Score included also
anthropometric parameters and lifestyle factors (categories of
age, BMI, and waist circumference; being or not physically active,
the frequency of eating fruit, vegetables and berries; have ever
taken antihypertensive medication regularly, having had a history
of high blood glucose and family history of diabetes) [8]. However,
we were obliged to assign an adapted FINDRISC score, because
one of the variables was not collected in our samples. We
calculated the FINDRISC personal score without using the
question on the personal history of high blood glucose, and in
the FINDRISC clinical score we included the FPG concentrations
instead of the information about the personal history of high blood
glucose. We repeated these analyses in the PREDIMED and DE-
PLAN-CAT cohorts.
The level of significance for all statistical tests was P,0.05 for
bilateral contrasts. Data were analyzed using the SPSS statistical
package version 17.0. To assess statistical differences between
ROC curves, EPIDATA 3.1 software was used.
Results
The baseline characteristics and differences between both
projects and those individuals in each project who developed
incident diabetes and those who did not are summarized in
Table 1. A total of 41.4% of the 1381 non diabetic subjects in this
subset from three PREDIMED centres were men, 23.1% had a
family history of diabetes and 17.6% were current smokers. The
mean age of the population was 67 years. Of all the subjects
analyzed, 155 (11.2%) developed diabetes during the mean of
4.75-year follow-up. A total of 35.5% of the subjects who
developed new onset T2DM reported a family history of diabetes
and 26.5% were current smokers; FPG was higher in this group
than in their non-incident diabetic counterparts (P,0.001)
(Table 1). In the DE-PLAN-CAT external validation sample,
33.3% of individuals were men, 69.2% had a family history of
diabetes and 37.5% were current smokers; the mean age was
similar (62 years) to the PREDIMED sample. Of the 552 non-
diabetic participants, 124 (22.4%) developed diabetes during the
mean of 4.2-year follow-up. Of the individuals with incident
diabetes, 62.1% reported a family history of diabetes, and 43.5%
were current smokers; FPG was also higher than among their non-
diabetic counterparts (p,0.001).
Relative risks (95% CI), ß-coefficients and points allocated to
each variable derived from Cox regression models were shown in
Table 2. Significant predictors of T2DM in models were selected
to develop the diabetes risk scores. Statistically significant
predictors of incident T2DM in the PREDIMED-personal model
were BMI$27 kg/m2 [HR (CI): 1.62 (1.07 to 2.42)], current
smoking [HR (CI): 1.54 (1.06 to 2.24)], family history of T2DM
[HR (CI): 2.02 (1.45 to 2.81)], and alcohol consumption [HR (CI):
1.94 (1.32 to 2.85)]. The PREDIMED-personal model included
these variables and also hypertension [HR (CI): 2.06 (0.96 to
4.45)], although it did not add any further predictive power to the
statistical model. Even so, we included it in our scores since it is
considered to be an important predictor of incident diabetes and it
was borderline significant in the personal model and significant
(P = 0.033) in the clinical model. The PREDIMED-clinical model
included the same variables as the personal model, but also FPG
[HR (CI): 6.88 (4.76 to 9.94)], which was the strongest predictor of
incident diabetes. The value for each variable of the PREDIMED
scores was defined from the ß-coefficient of the personal model,
except for the FPG (Table 2). For ß = 0.01–0.20, the weight was 1;
for ß = 0.21–0.8, the weight was 2; for ß = 0.81–1.20, the weight
Risk Score to Predict Type 2 Diabetes Mellitus
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was 3; for ß = 1.21–2.20, the weight was 4, and for ß.2.21 the
weight was 5. The lowest category of each variable was given a
weight of 0 whereas for the highest category, the score allocated to
each variable was given. The total PREDIMED-personal score
was calculated as the sum of risk factors and varied from 0 to
10 points. The PREDIMED-clinical score was the sum of all
variables included in the clinical model and varied from 0 to
14 points.
In Table 3, the incidence of diabetes during follow-up was
classified according to the score range in which individuals were
categorized. It was high in the two upper categories of our clinical
score in both the PREDIMED derivation sample and DE-PLAN-
CAT validation sample. In the PREDIMED study, the percentage
of individuals diagnosed with incident diabetes in the middle (5 to
9 points) and the highest (10 to 14 points) categories of the clinical
score was 13.6% and 36.5% respectively. The P for trend of the
score performance in the derivation sample was ,0.001. A cut
point of $6 in our clinical score identified 88.4% of the incident
cases of diabetes. In the external validation sample (DE-PLAN-
CAT cohort), the observed incidence was also high in the middle
and the highest categories of our clinical score (P for trend
,0.001). A total of 86% of subjects who developed new onset
diabetes had 6 or more points based on our clinical score. The
areas under the ROC curves of several diabetes risk scores assessed
in both samples (derivation and validation) are shown in Table 4.
Our clinical score reasonably predicted incident diabetes in the
derivation sample (PREDIMED study subset) and had an
AUC = 0.78. This AUC significantly outperformed the areas
Table 2. Baseline risk factors for incidence of type 2 diabetes in the PREDIMED cohort (Cox regression model).
PREDIMED-personal model: n = 1381 (Incident diabetes:
n = 155)
PREDIMED-clinical model: n = 1381 (Incident diabetes:
n = 155)
Risk factor Hazard ratio (95% CI) b P value Score Hazard ratio (95% CI) b P value Score
BMI$27 kg/m2 1.62 (1.07–2.42) 0.486 0.022 2 1.37 (0.90–2.08) 0.315 0.140 2
Current smoker 1.54 (1.06–2.24) 0.435 0.023 2 1.72 (1.18–2.52) 0.547 0.005 2
Family history of T2DM 2.02 (1.45–2.81) 0.705 ,0.001 2 1.65 (1.19–2.31) 0.506 0.003 2
Alcohol consumption 1.94 (1.32–2.85) 0.666 0.001 2 1.53 (1.04–2.26) 0.427 0.031 2
Hypertension 2.06 (0.96–4.45) 0.727 0.063 2 2.31 (1.06–5.00) 0.838 0.033 2
FPG$100 mg/dL - - - - 6.88 (4.76–9.94) 1.929 ,0.001 4
TOTAL SCORE - - - 10 - - - 14
Abbreviations: T2DM, Type 2 Diabetes Mellitus; BMI, body mass index; SDU, standard drink unit; CI, confidence interval; FPG, Fasting Plasma Glucose. One standard drink unit
corresponds to 10 grams of pure alcohol. Alcohol consumption is considered when $1.5 SDU in women or $3 in men. Hypertension is considered when subjects use blood
pressure medication or when pressure level$130/85 mmHg. All models were adjusted by intervention group. The score values were estimated on the basis of the b coefficients
of the Cox regression models.
doi:10.1371/journal.pone.0033437.t002
Table 1. Baseline characteristics of the study participants.
PREDIMED derivation sample (3 centres) DE-PLAN-CAT validation sample
Characteristic
Total subjects
(n = 1381)
NIDM
(n = 1226)
IDM
(n = 155) Pvaluea
Total subjects
(n = 552)
NIDM
(n = 428)
IDM
(n = 124) Pvaluea Pvalueb
Age, years 67 (6) 67 (6) 66 (5) 0.142 62 (7) 62 (8) 62 (7) 0.653 ,0.001
Men, n (%) 572 (41.4) 499 (40.7) 73 (47.1) 0.128 184 (33.3) 131 (30.6) 53 (42.7) 0.012 0.001
Weight, kg 75.3 (11.0) 75.0 (11.0) 78.3 (11.2) ,0.001 78.9 (12.9) 78.0 (12.4) 81.9 (14.1) 0.003 ,0.001
BMI, kg/m2 29.4 (3.2) 29.3 (3.2) 30.1 (3.1) 0.004 31.2 (4.6) 30.9 (4.4) 32.0 (5.1) 0.027 ,0.001
Waist circumference, cm 97.9 (9.9) 97.5 (9.8) 101.6 (9.4) ,0.001 100.6 (10.6) 99.9 (10.2) 102.7 (11.7) 0.012 ,0.001
Family history of diabetes, n (%) 319 (23.1) 264 (21.5) 55 (35.5) ,0.001 382 (69.2) 305 (71.3) 77 (62.1) 0.052 ,0.001
Current smoker, n (%) 243 (17.6) 202 (16.5) 41 (26.5) 0.002 207 (37.5) 153 (35.7) 54 (43.5) 0.114 ,0.001
Systolic blood pressure, mmHg 151.4 (20.2) 151.1 (20.2) 154.1 (19.6) 0.079 134.0 (14.3) 133.5 (13.6) 135.5 (16.4) 0.209 ,0.001
Diastolic blood pressure, mmHg 85.6 (10.2) 85.4 (10.2) 87.0 (10.3) 0.078 80.1 (9.1) 79.5 (9.1) 82.0 (9.2) 0.009 ,0.001
Total cholesterol, mg/dL 223.5 (37.1) 224.0 (36.4) 219.3 (41.8) 0.138 211.2 (36.2) 211.6 (36.2) 210.1 (36.6) 0.684 0.084
HDL cholesterol, mg/dL 56.8 (14.2) 57.3 (14.3) 53.2 (12.5) ,0.001 58.2 (14.9) 59.1 (15.5) 55.1 (12.2) 0.003 0.054
LDL cholesterol, mg/dL 142.1 (32.2) 142.7 (32.3) 137.6 (31.1) 0.072 127.9 (32.1) 127.8 (31.7) 128.2 (33.5) 0.901 ,0.001
Triglycerides, mg/dL 133.4 (72.0) 130.7 (64.6) 155.3 (112.9) 0.009 126.9 (68.2) 122.2 (59.9) 143.4 (89.5) 0.016 0.069
Fasting glucose, mg/dL 96.6 (15.0) 94.6 (13.4) 112.3 (17.7) ,0.001 94.1 (12.7) 91.9 (11.7) 101.8 (12.8) ,0.001 0.001
Abbreviations: BMI, body mass index. HDL, high-density lipoprotein; IDM, incident Diabetes Mellitus; LDL, low-density lipoprotein, NIDM, non incident Diabetes Mellitus.
Data expressed as mean (SD) or number (percent). P valuea of the difference between incident diabetic and non-incident diabetic subjects. P valueb of the difference between
individuals in the derivation sample and individuals in the validation sample (T-test for continuous variables or Chi-square tests for categorical variables).
doi:10.1371/journal.pone.0033437.t001
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under the curve of our personal score (0.64), the FINDRISC
personal and clinical scores (AUC = 0.58 and 0.71, respectively)
and the GDRS (AUC = 0.59) when they were applied to the
PREDIMED derivation sample (P,0.05 when the clinical score
was compared to the other scores tested). Our personal score also
had a higher AUC than the FINDRISC personal score and the
GDRS (P,0.05). The sensitivity and specificity of our clinical
score for identifying undiagnosed diabetes at a cutoff of $6 points
were 72.2% and 72.5%, respectively. The positive predictive value
was 25% and the negative predictive value was 95.4%.
When we analyzed the ROC curves of several scores in the
validation sample (DE-PLAN-CAT), we observed that our clinical
score also had a higher AUC than other models (AUC = 0.66). In
comparison to the FINDRISC (AUC = 0.61) and the GDRS
(AUC = 0.58) scores, our score had a higher predictive ability
(P,0.001) in this external validation sample. As expected, the
AUC for our personal models were lower when tested in the
validation sample (DE-PLAN-CAT) than in the derivation sample
(PREDIMED cohort; for our personal score, the AUC was of
0.50, and for the FINDRISC personal score it was 0.52). When
only individuals at the same range of age and BMI as in the
PREDIMED study were considered as validation sample, the
AUC of the PREDIMED-clinical Score remain significantly
higher than those of the FINDRISC (data not shown). There
were no statistically significant differences between them. For a cut
point of $6 of our clinical score, sensitivity was 85.4% and
specificity was 26.6% in the cohort in which scores were tested.
The positive predictive for this score in the validation sample value
was 25.2% and the negative predictive value was 86.4%.
Discussion
Identifying individuals at high risk of developing T2DM is
essential to lead this target population the preventive actions,
minimizing human and economic costs of diabetic complications
[21]. Therefore, we developed two diabetes risk scores, the
PREDIMED-personal Score including only information easily
obtained by simple questions; and the PREDIMED-clinical score,
which added FPG to the model in order to have a simple and
useful tool for predicting the risk of diabetes in clinical practice.
The present study shows that the PREDIMED-clinical score had
good sensitivity, specificity and negative predictive value but lower
positive predictive value for identifying those elderly individuals at
high risk of developing diabetes in Spanish population at high
cardiovascular risk; and had a higher predictive ability than other
common diabetes risk scores used in clinical settings.
As far as we know, our study is the first to have analyzed
classical predictors of diabetes in an elderly Mediterranean
population at high cardiovascular risk. This is important because
previous diabetes risk scores were developed in healthy European
populations in which lifestyle and ethnicities, the main factors that
influence the risk of developing diabetes, differ from those of
elderly Spanish individuals, thus limiting their applicability
[9,12,22].
The diabetes risk scores derived from this subset of the
PREDIMED cohort are simple to apply in clinical practice
because they are based on variables routinely gathered in primary
care, and FPG. They avoid, therefore, the complex and time-
consuming biochemical measurements used in other clinical scores
[13]. FPG was included in our clinical score because it can
considerably improve the performance of models based on non-
invasive measures [23]. Thus, it gives clinicians the opportunity to
choose the score depending on the availability of FPG.
As in other published studies, BMI, family history of T2DM and
hypertension have been identified as risk factors of T2DM. Other
lifestyle-related factors that have been established as increasing the
risk of diabetes [8,9,11,12,24], such as smoking or alcohol
consumption, have also been identified as significant predictors
of incident diabetes in our study.
Although age has been considered as a major risk factor for
T2DM in several studies, including the San Antonio Heart Study
[12], the GDRS [11] and the FINDRISC analysis [8], it was not
significantly associated with a higher risk of incident diabetes in
our population. This might be because the age range in our study
was, by design, too narrow. Nevertheless, our results in relation to
age are consistent with other studies which showed a non-
significant association within these variables in the results of their
multivariate regression models [23].
The FINDRISC diabetes score, developed in a random Finnish
population sample of 35 to 64 year-old men and women, included
risk factors that were similar to the PREDIMED diabetes risk
scores (BMI, antihypertensive medication, history of blood
glucose) [8]. For this reason, and because it is widely used for
the screening of individuals at high risk of T2DM, we tried to
assess its performance in our population. The GDRS, which was
used in the EPIC-Potsdam study in a population of individuals
aged 55–65 years, also included risk factors which had been
considered in PREDIMED scores, such as alcohol consumption,
hypertension or smoking [11]. In the present study, the AUC for
the PREDIMED-clinical score was 0.78; in the ARIC study, the
AUC for the clinical score, which included variables similar to
those in our model (parental history of diabetes, blood pressure
and FPG) was also 0.78 [9]. In the PREDIMED-clinical score, a
cut-off point of 6 gave a sensitivity of 72.2% and a specificity of
72.5%, and so was optimal for identifying individuals at risk of
Table 3. Diabetes incidence by categories of the Clinical Score during follow-up in the PREDIMED derivation sample and the DE-
PLAN-CAT validation sample.
PREDIMED derivation sample DE-PLAN-CAT validation sample
PREDIMED-clinical Score Total subjects Incident diabetes %a Total subjects Incident diabetes %a
0–4 658 18 2.7 132 18 13.6
5–9 556 76 13.6 303 58 19.1
10–14 167 61 36.5 117 48 41.0
P for trend ,0.001 ,0.001
Total subjects 1381 155 552 124
aPercentage of individuals with incident diabetes in each category of PREDIMED-clinical Score.
doi:10.1371/journal.pone.0033437.t003
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developing type 2 diabetes in an elderly population at high
cardiovascular risk.
When we tried to test PREDIMED diabetes risk scores in an
independent external validation sample, the AUC was slightly
lower than the estimates obtained in the population in which the
score was derived. However, validating risk scores in different
populations is likely to result in poorer performance, so the present
study is consistent with the results of previous studies [13]. This
was observed when the FINDRISC was tested in The Netherlands
[25] and when the Framingham offspring diabetes risk score [23]
was validated in the Botnia Study [26].
One of the strengths of the current study was that our analysis
showed that the AUC of the PREDIMED-clinical score was
significantly higher in both the derivation and validation sample
than that of other scores when applied to the same samples
(FINDRISC and GDRS). Moreover, our scores used fewer
variables than other scores, thus saving clinicians time and effort.
Another important issue worth mentioning is that in both the
studies used for the analyses, the diagnosis of T2DM was
confirmed by a second test, thus providing better identification
of new cases of T2DM. One of the limitations inherent to other
studies is that diabetes was self-reported, which leads to an
underestimation of the diagnosis of incident diabetes. We used
only three of the earlier cohorts from the PREDIMED trial
because they had the longest follow-ups, and the procedures for
comprehensively ascertaining new-onset diabetes cases were more
complete. In fact, it is reassuring to observe that the incidence of
diabetes in our population (11.2%) was similar to that observed in
previous studies such as the San Antonio Heart Study (9.2%) [12]
and the Diabetes Prevention Program (13%) [27].
Our study has several limitations. First, the analyses were
conducted in an elderly population at high risk for CVD, so the
results may not be extrapolatable to the general population.
Second, the derivation and validation samples differ in general
characteristics. However, when we considered as validation
sample only subjects of the same range of age and BMI than the
derivation population, the performance of our scores did not
significantly change. Third, it should be kept in mind that the
subjects of our cohorts were allocated to different lifestyle
interventions that could partially account for the incidence of
new onset diabetes. However in our statistical analyses we adjusted
all our estimates for the interventions. In addition, some of the
data that the FINDRISC score required to calculate the risk of
diabetes was not available in our population, so we had to apply an
adapted version of the FINDRISC score. Finally, although our
clinical score showed good sensitivity in both the derivation and
validation samples, the specificity and PPV was relatively low, as
has been observed for other published scores [28,29].
In summary, in a sample of three PREDIMED centres, we have
identified a set of classical diabetes risk factors and developed a
diabetes risk score based on anthropometric measurements,
lifestyle, and fasting plasma glucose, which is efficient at predicting
elderly individuals at high risk of developing T2DM in a
population of Spanish Mediterranean individuals at high cardio-
vascular risk.
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